Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 1,130 | 1,220 | 970 | 1,190 | 630 |
| TOTAL | $1,130 | $1,220 | $970 | $1,190 | $630 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 7,820 | 8,530 | 8,570 | 8,560 | 700 |
| TOTAL | $7,820 | $8,530 | $8,570 | $8,560 | $700 |
| Total Assets | $8,950 | $9,750 | $9,540 | $9,750 | $1,330 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 70 | 70 | 70 | 70 |
| Accounts payable and accrued liabilities | 4,000 | 3,900 | 5,120 | 5,790 | 3,830 |
| Other current liabilities | 0 | 0 | 0 | 30 | 320 |
| TOTAL | $4,050 | $3,970 | $5,190 | $5,890 | $4,220 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,450 | 2,480 | 2,450 | 0 | 2,530 |
| TOTAL | $2,450 | $2,480 | $2,450 | $N/A | $4,200 |
| Total Liabilities | $6,500 | $6,450 | $7,640 | $5,890 | $8,420 |
| Shareholders' Equity | |||||
| Common Shares | 150 | 120 | 120 | 110 | 90 |
| Other shareholders' equity | 0 | 0 | 0 | -1 | -2 |
| TOTAL | $425,800 | $401,780 | $401,760 | $381,459 | $372,208 |
| Total Liabilities And Equity | $432,300 | $408,230 | $409,400 | $387,349 | $380,628 |